Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

250.68
+6.142.51%
Post-market: 250.680.00000.00%19:58 EDT
Volume:1.22M
Turnover:305.50M
Market Cap:16.27B
PE:17.14
High:252.72
Open:241.39
Low:241.39
Close:244.54
52wk High:266.38
52wk Low:123.88
Shares:64.91M
Float Shares:62.69M
Volume Ratio:0.59
T/O Rate:1.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.39
PE(LYR):-42.92

Loading ...

Raymond James Reaffirms Their Buy Rating on Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
May 06

Jazz Pharmaceuticals Plc : Raymond James Raises Target Price to $239 From $227

THOMSON REUTERS
·
May 06

Piper Sandler Sticks to Its Buy Rating for Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
May 06

Analysts Conflicted on These Healthcare Names: Jazz Pharmaceuticals (JAZZ), Dianthus Therapeutics (DNTH) and Waters (WAT)

TIPRANKS
·
May 06

Jazz Pharmaceuticals Plc : RBC Raises Target Price to $258 From $195

THOMSON REUTERS
·
May 06

Stock Track | Jazz Pharmaceuticals Soars 5.53% in Pre-Market on Strong Q1 Earnings Beat and Reaffirmed Guidance

Stock Track
·
May 06

Stock Track | Jazz Pharmaceuticals Soars 5.53% in Night Session on Strong Q1 Earnings Beat and Reaffirmed Guidance

Stock Track
·
May 06

Jazz Pharmaceuticals Plc : Jefferies Raises Target Price to $245 From $232

THOMSON REUTERS
·
May 06

Jazz Pharmaceuticals Plc : TD Cowen Raises Target Price to $275 From $220

THOMSON REUTERS
·
May 06

Jazz Pharmaceuticals Plc : Leerink Partners Raises Target Price to $235 From $225

THOMSON REUTERS
·
May 06

Jazz Pharmaceuticals Plc : Baird Raises Target Price to $252 From $209

THOMSON REUTERS
·
May 06

Stock Track | Jazz Pharmaceuticals Soars 5.02% in Post-Market on Strong Q1 Earnings Beat and Reaffirmed Guidance

Stock Track
·
May 06

Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ) and SOPHiA GENETICS (SOPH)

TIPRANKS
·
May 06

Stock Track | Jazz Pharmaceuticals Soars 5.93% After-Hours on Strong Q1 Earnings Beat and Reaffirmed Guidance

Stock Track
·
May 06

Ireland's Jazz Pharmaceuticals Q1 revenue beats estimates, reaffirms FY outlook

Reuters
·
May 06

Jazz director Bruce Cozadd disposes of $1.22 million Jazz Pharmaceuticals shares

Reuters
·
May 06

GUIDANCE: (JAZZ) Jazz Pharmaceuticals Expects Full Year 2026 Revenue Range $4.25B - $4.50B, vs. FactSet Est of $4.44B

MT Newswires Live
·
May 06

BRIEF-Jazz Pharmaceuticals Q1 Adjusted EPS USD 6.34 Vs. IBES Estimate USD 4.57

Reuters
·
May 06

Jazz Pharmaceuticals Plc: Company Reaffirms 2026 Revenue and Expense Guidance

THOMSON REUTERS
·
May 06

FOCUS-Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification

Reuters
·
Apr 30